Globucel Solution for Infusion contains Human Normal Immunoglobulin (5gm) and is indicated for the treatment and prevention of various immunodeficiency disorders. This sterile, purified preparation of immunoglobulin G (IgG) is derived from pooled human plasma and provides passive immunity by supplying a broad spectrum of antibodies against a wide range of pathogens. Globucel is primarily used in patients with primary humoral immunodeficiency, such as common variable immunodeficiency (CVID) and X-linked agammaglobulinemia, to reduce the frequency and severity of infections. It is also employed in certain autoimmune and inflammatory conditions where modulation of the immune system is beneficial. The solution is administered via intravenous infusion under medical supervision, with dosage and frequency tailored to the individual patient's clinical status and serum IgG levels. Adverse reactions may include infusion-related symptoms such as headache, chills, fever, and rarely, hypersensitivity reactions. Pre-infusion assessment and monitoring are essential to minimize risks. Globucel should be used cautiously in patients with a history of hypersensitivity to immunoglobulins or IgA deficiency. Proper storage and handling are crucial to maintain product efficacy. Globucel Solution for Infusion represents a vital therapeutic option for immunocompromised patients requiring immunoglobulin replacement therapy.